WeVote
Log In

Bill

Bill

HB 973

Medicaid; provide coverage for rapid whole genome sequencing for certain persons.

2025 Regular Session Introduced by Clay Mansell

HB 973 would have expanded Mississippi Medicaid coverage to include rapid whole genome sequencing for eligible patients, but died in committee without advancing to a vote.

Died In Committee
#appropriationsd #medicaid
0
WeVote Research Nonpartisan
Bill Summary · HB 973

Legislative bill overview

HB 973 would have required Mississippi's Medicaid program to cover rapid whole genome sequencing for certain eligible individuals. The bill specified criteria for which patients could access this advanced genetic testing through state Medicaid funds, though specific eligibility requirements are not detailed in the available information.

Why is this important

Whole genome sequencing can provide comprehensive genetic information for diagnosis, treatment planning, and disease prevention, potentially improving health outcomes for patients with complex or undiagnosed conditions. However, this represents a significant expansion of Medicaid coverage for an expensive diagnostic technology, raising questions about cost-effectiveness, budget impact, and which conditions justify such testing.

Potential points of contention

  • Cost and fiscal impact: Rapid whole genome sequencing is expensive; expanding coverage could substantially increase Medicaid expenditures without clear guidance on which conditions qualify
  • Medical necessity standards: Determining which patients genuinely need whole genome sequencing versus more targeted genetic testing involves complex clinical judgment and potential for overutilization
  • Implementation and infrastructure: Mississippi's Medicaid program would need to establish protocols, approve providers, and manage a technology that requires specialized expertise for result interpretation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.